true... looking back the delay of market release and missed opportunities is a disappointing to everyone - the business partners, the investors, the interested clients. it is especially disappointing, as the delay does not come from the sensor technology itself, but seemingly from a design flaw of the system. despite this, they have reiterated significant demand and were looking for additional funding for up to 100x greater production volume. (another case of overconfidence?)
looking forward... they are working on a platform technology to detect biomarkers in the PoC space. it allows applications beyond COVID. but wrt to Covid, it will find its space in hospitals and corporations, especially for the detection of asymptomatic covid cases. NA and Europe will go into another Winter, where COVID will still be present and the need for testing will be there.
SE1 Price at posting:
5.7¢ Sentiment: Buy Disclosure: Held
